Question · asked by 1 review
Lactobacillus salivarius WB21 tablets vs placebo (3 tablets/4 times a day: OLT and VSC scores
- Population
- Adolescents and adults aged over 16 years with clinical or self-assessed halitosis of oral origin; excluding induced or physiological halitosis, non-oral halitosis, and severe chronic periodontitis (clinical attachment level 5 mm or more)
- Intervention
- Lactobacillus salivarius WB21 tablets
- Comparison
- placebo (3 tablets/4 times a day
- Outcome
- OLT and VSC scores
What each review found
Include earlier review versions| Finding | Effect | Studies | GRADE certainty |
|---|---|---|---|
Lactobacillus salivarius WB21 tablets vs Placebo tablets OLT scores and VSC scores (gas chromatography) · Adolescents and adults aged over 16 years with clinical or self-assessed halitosis of oral origin; excluding induced… Interventions for managing halitosis (2019) · Cochrane All outcomes | Suzuki 2014 (cross-over RCT) compared Lactobacillus salivarius WB21 tablets versus placebo tablets (OLT and VSC by gas chromatography). The trial did not give usable data and we could not extract data from the graph. | 1 study | GRADE not reported |
Findings are shown side by side, never pooled across reviews.
The reviews
| Review | Searched up to | Included studies | AMSTAR 2 |
|---|---|---|---|
| Interventions for managing halitosis 2019 · Cochrane All outcomes | 2019-04 | Not listed | Not assessed |
How reviews are matched to this question
Reviews word the same question differently. Four decision models (TypeSafe's Jev, Liquid AI's d1-ultra, SubQ Snap and Baseten's Elephant) judged each wording of the population, intervention, comparator and outcome against the others; two wordings count as the same when at least three of them agree and none clearly disagrees, and findings count as this question only when all four elements match. Timing, setting and subgroup never split a question: they are shown on each finding.